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Isoniazida b s t r a c t
Isoniazid (INH) is a pro-drug that has been extensively used to treat tuberculosis. INH is activated by
the heme enzyme catalase–peroxidase (KatG), but the mechanism of the activation is poorly under-
stood, in part because the INH binding site has not been clearly established. Here, we observed that a
single-residue mutation of KatG from Synechococcus elongatus PCC7942 (SeKatG), W78F, enhances
INH activation. The crystal structure of INH-bound KatG-W78F revealed that INH binds to the heme
pocket. The results of a thermal-shift assay implied that the ﬂexibility of the SeKatG molecule is
increased by the W78F mutation, allowing the INH molecule to easily invade the heme pocket
through the access channel on the c-edge side of the heme.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Isoniazid (INH) is a pro-drug that has been extensively used as a
ﬁrst-choice drug for the tuberculosis chemotherapy. A decade-long
genetic and biochemical investigations revealed that INH is acti-
vated by the catalase–peroxidase KatG ofMycobacterium tuberculo-
sis [1–3]. Originally, KatG proteins were identiﬁed as bi-functional
heme enzymes belonging to the class I peroxidase family. In
contrast to monofunctional peroxidases, these enzymes exhibit
both catalase activity and broad-spectrum peroxidase activity.
The INH activation ability of KatG was identiﬁed by analysis of
an INH-resistant M. tuberculosis species [1]. During activation, the
INH molecule is cleaved by KatG to generate an isonicotinyl radical
(IN); subsequently, in the presence of superoxide, the IN radicalcombines with NAD+ to generate an isonicotinyl-NAD (INNAD)
covalent adduct [4]. The INNAD adduct inhibits the InhA enzyme,
which is involved in the synthesis of mycolic acid [2], a major
unique component of the mycobacterial cell wall. In contrast to
the inhibitory mechanism of InhA by INNAD adduct [2], which
has been clearly elucidated, the detailed mechanisms of INH acti-
vation by KatG remain unclear, and the exact binding site of INH
on KatG is unknown.
The mechanisms of INH activation have been explored not only
inM. tuberculosis KatG (MtKatG) [5–7] but also in other KatGs such
as those of Burkholderia pseudomallei (BpKatG) [4,8–10], Synechocy-
tis PCC 6803 (SynKatG) [11–13] and Synechococcus elongatus
PCC7942 (SeKatG) [14]. These KatGs share at least 54% sequence
identity, and their overall structures are very similar [15–17]. In
addition, the conﬁguration of the residues around the heme,
including the unique covalent bonds among the side chains of
the Met–Tyr–Trp residues of KatG, located on the distal side of
the heme, are found in KatG proteins from all three species. There-
fore, the environments of the heme pocket in MtKatG, BpKatG,
SynKatG and SeKatG are believed to be almost identical.
To date, information regarding the INH binding site of KatG has
primarily been obtained by spectroscopic studies. The results of
Table 1
Data collection and crystallographic analysis.*
INH-bound
KatG-W78F
INH-free KatG-W78F
Data collection
Beamline SPring-8
BL44XU
SPring-8 BL44XU
Space group P41212 P41212
Unit cell
a, b, c (Å) 107.7, 107.7,
204.8
108.3, 108.3, 203.3
a, b, c () 90.0, 90.0,
90.0
90.0, 90.0, 90.0
Wavelength (Å) 0.9000 0.9000
Resolution (Å) 50.0–3.20
(3.31–3.20)
50.0–2.65 (2.74–2.65)
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activation process occurs in the vicinity of the heme: Raman
spectroscopy intensities reveal that upon treatment with INH,
the binding of INH perturbs bound CO in the distal heme pocket
of MtKatG [18]; similarly, the characteristic UV–visible spectrum
of the oxoferryl species (Fe(IV)@O) in BpKatG changes rapidly upon
addition of INH [4]. In addition, electron paramagnetic resonance
spectroscopy demonstrated that the heme-derived signal changes
upon addition of INH [19].
Interestingly, electron paramagnetic resonance (EPR) experi-
ments clearly demonstrated that KatG has several sites of the rad-
ical intermediate in the enzymatic reaction, and the site was differ
among the KatGs; in the MtKatG [Fe(IV)@O Trp] species was the
reactive intermediate with the INH reaction [20], whereas in the
SynKatG the ﬁrst committed intermediate, identiﬁed as the Trp
and a Tyr, formed subsequently to the stable [Fe(IV@O) Porphy-
rin+] species by intermolecular electron transfer [13]. More
recently, we determined the structure of the INH-bound SeKatG
[14], which revealed that three INH molecules are weakly bound
to the molecular surface (Fig. 1); one INH molecule was bound at
the entrance to the e-edge side of heme (Site 1). Another was
bound at the entrance to the c-edge side of heme (Site 2), and
the other was bound to the loop structures in front of the heme
propionate side chain (Site 3). All of the interactions between KatG
and the bound INH seemed to be weak, mediated mainly by van
der Waals contacts. In contrast, crystallographic analysis of
INH-bound BpKatG demonstrated that one INH molecule binds to
the molecular surface at the dimer interface, a site that is 20 Å
distant from the entrance to the heme cavity [4]. Subsequent
mutation experiments demonstrated that the residues involved
in INH binding, as revealed by the structure, had no effect on
INH activation; therefore, this remote site is not the only binding
site for INH [4]. Taken together, the INH-binding sites of SeKatG
and BpKatG are probably different, and the exact binding site of
INH on KatG is still controversial.
During the course of a mutational study of SeKatG, aimed at
investigating the localization of the radical during the reaction,
we observed that a single-residue mutation in SeKatG, W78F,
enhanced INH activation. The mutated tryptophan residue (W78),
which is highly conserved in all KatG orthologues, is located at
the entrance of the c-edge side of the heme (Site 2) [15–17,21].
The side chain of the tryptophan shielded the c-edge–side heme-
access channel, and thus seemed to function as the ‘‘lid’’ of the
heme pocket. In order to gain a better understanding of INH
recognition/binding, we determined the crystal structures of
the SeKatG-W78F mutant protein. The single-residue mutationFig. 1. The locations of the INH-binding sites in the wild-type SeKatG. The wild-
type SeKatG has three low-afﬁnity INH binding sites (Site 1–3). Three INH
molecules bound on the molecular surface via van der Waals contacts. The
molecular surface drawing is overlain with the cartoon drawing of the INH-bound
wild-type SeKatG (PDB ID: 3WXO). The bound INH molecules and heme are shown
in yellow and pink. Trp78 is shown in orange.resulted in dramatic alteration of the INH-binding site relative to
that of the wild type: in SeKatG-W78F, the INH molecule bound
in the heme pocket, whereas in wild-type SeKatG, three INH mol-
ecules bound on the molecular surface.
2. Materials and methods
2.1. Expression, puriﬁcation, and characterization
Oligonucleotide-directed mutagenesis of Trp78 to Phenylala-
nine in SeKatG was performed by overlap extension PCR using
the pET-3a plasmid containing the SeKatG gene as the template
[17]. The oligonucleotide pair 50-CCAAGACTGGTTTCCGGCAG-
ACTG-30 and 50-CAGTCTGCCGGAAACCAGTCTTGG-30 was used to
produce the SeKatG-W78F mutant. The plasmids were transformed
into Escherichia coli strain BL21(DE3). Protein overexpression and
puriﬁcation were carried out as described for native SeKatG [22].
2.2. Crystallization, X-ray diffraction data collection, and structure
determination
Crystals of SeKatG-W78F were successfully obtained under the
same conditions (4.3 M sodium formate, with 0.1 M sodium citrate
[pH 6.3] as a precipitant) used for the native SeKatG. INH-bound
crystals were prepared by soaking the crystals of SeKaG-W78F in
crystallization solution containing 100 mM INH for 12 h. On
beamline BL44XU at SPring-8 (Japan Synchrotron Radiation
Research Institute), X-ray diffraction data of INH-bound and INH-
free SeKatG-W78F were obtained to 3.2 Å and 2.65 Å resolution,
respectively, from a ﬂash-cooled crystal, which did not requireCompleteness (%) 99.8 (99.8) 99.9 (99.4)
Redundancy 5.2 (4.6) 6.8 (6.4)
I/r (I) 16.3 (3.0) 10.4 (5.7)
Rmerge
 0.111 (0.532) 0.169 (0.491)
Reﬁnement
Resolution (Å) 50.0–3.20 50.0–2.65
No. of reﬂections 19354 33798
R/Rfree 0.180/0.260 0.196/0.254
RMSD bond lengths (Å) 0.01 0.017
RMSD bond angles () 1.52 1.92
Average B value (Å2) 73.1 49.3
Ramachandran plot
Most favored region (%) 90.8 87.9
Additionally allowed regions (%) 7.8 12.1
Generously allowed regions (%) 1.4 0
PDB ID 4PAE 3X16
* The statistics in the highest-resolution shell are given in parentheses.
 Rmerge = Rhkl Ri |Ii(hkl)  hI(hkl)i|/RhklRi Ii(hkl), where Ii(hkl) is the observed
intensity and hI(hkl)i is the average intensity for multiple measurements.
 R = Rhkl ||Fobs|  |Fcalc||/Rhkl |Fobs|, where Fobs is the observed structure factor and
Fcalc is the calculated structure factor. Rfree is the same as R, except calculated using
5% of the data that were not included in any reﬁnement calculations.
Fig. 2. Crystal structure of SeKatG-W78F in complex with INH, and a comparison of the heme cavity between the wild type and W78F mutant. (A) Overall structure of INH-
bound SeKatG-W78F. The dimeric structure of SeKatG-W78F was generated via a symmetry operation using the crystallographic 2-fold axis. The individual subunits are
shown in purple or cyan. The bound INHmolecules, hemes, and cations are shown in yellow, pink, and red, respectively. (B–E) Comparison of the electron-density maps of the
INH-free wild-type SeKatG (PDB ID: 3WNU), INH-bound wild-type SeKatG (PDB ID: 3WXO), INH-free SeKatG-W78F (PDB ID: 3X16) and INH-bound SeKatG-W78F. An Fo–Fc
map omitting the INH molecule, contoured at 3.0r (red), is overlaid on a stick model of the bound INH. Water molecules are shown as red balls, and the blue broken line
indicates a hydrogen bond.
S. Kamachi et al. / FEBS Letters 589 (2015) 131–137 133the addition of other cryoprotectants. The data set was processed
and scaled using the HKL-2000 package [23].
Crystals of INH-bound SeKatG-W78F were nearly isomorphous
with those of native KatG, and the structure of SeKatG-W78F was
determined using the structure of the native KatG (PDB ID:
3WNU) as a model [17]. The structure was subjected to rigid-body
reﬁnement using Refmac5 [24] from the CCP4 package [25]. The
structure was further reﬁned by restrained reﬁnement in Refmac5,
and manual model revision was carried out using COOT [26]. The
electron-density map at the ﬁnal stage was clear enough to pre-
cisely assign the orientation of the bound INH molecules. Details
of the data collection and reﬁnement statistics are summarized
in Table 1. The coordinates and structure factors have been depos-
ited at the RCSB Protein Data Bank under accession codes 4PAE
(INH-bound SeKatG) and 3X16 (INH-free SeKatG).
2.3. Enzymatic INNAD formation by SeKatG W78F
INNAD formation activity was assayed at 37 C using a reaction
mixture containing 0.4 mM NAD+, 1.0 mM INH, 2 lM MnCl2,50 mM Tris–HCl (pH 7.8), and 50 lg/ml enzyme. INNAD formation
was monitored at 326 nm (e = 6900 M1 cm1) using a V630BIO
spectrometer (JASCO). Km values for INH were determined using
reaction mixtures containing various concentrations of INH (0.5,
1.25, 2.5, 5, 10, 20, 40 mM). The non-enzymatic reaction was esti-
mated using the same reaction mixture without enzyme, and the
result was used for the background value in calculations of enzy-
matic activity. The enzyme kinetic parameters were estimated by
non-linear least-squares curve ﬁtting in Microsoft Excel Solver.
2.4. Thermal shift assays of SeKatG-W78F
Thermal shift assays were performed on a CFX96 Real-Time PCR
Cycler (Bio-Rad Laboratories). In a typical experiment, 1 ll of
SYPRO Orange (Sigma–Aldrich, diluted from 5000 stock into
50 mM Tris–HCl, pH 7.8), 4 ll protein (0.4 mg/ml), and 5 ll buffer
(50 mM Tris–HCl, pH 7.8) were mixed on ice in a white 96-well
PCR plate (Bio-Rad Laboratories). To evaluate the effect of INH bind-
ing, 1 ll of 5000 SYPRO Orange, 4 ll protein (0.4 mg/ml), 1 ll INH
(10 mM), and 4 ll Tris–HCl buffer were mixed. Fluorescence was
Table 2
Steady-state kinetics of INNAD formation by wild-type SeKatG and SeKatG-W78F.
Apparent speciﬁc activitya (nmol/min/mg protein) kcatb (min1) Km INH (mM) kcat/Km (S1 mM1)
SeKatG wild-type 33.3 ± 6.3 43.9 5.6 0.13
SeKatG W78F 131.8 ± 8.7 38.8 1.3 0.50
a The apparent speciﬁc activities were evaluated at 37 C using a reaction mixture containing 0.4 mM NAD+, 1.0 mM INH, 2 lMMnCl2, 50 mM Tris–HCl, pH 7.8. The SeKatG
and it variant concentrations were determined by using the absorbance at 280 nm (e = 177270 M1 cm1).
b The turnover number is deﬁned as that rate at which the enzyme can produce ININH per heme per unit time. The bound heme concentration was determined by using
the absorbance at 405 nm (e = 100 mM1 cm1).
Fig. 3. Alteration of SeKatG by introduction of the W78F mutation. (A and B) A
structural comparison of the entrance of the c-edge side of heme in the INH-bound
forms of wild-type SeKatG and SeKatG-W78F. Residue 78 (the mutated site) is
shown in orange. The bound INH molecule and heme are shown in yellow and pink.
(C) Thermal-shift assays of the wild type and W78F mutant. Inverse ﬁrst-derivative
plots of wild type (white) and W78F (purple). Average Tm values are shown
alongside each curve. n = 3 for each assay.
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490 nm; detection, 560–580 nm). All measurements were
performed three times. Data evaluation andmelting-point determi-
nation were conducted using the Bio-Rad CFX Manager software.3. Results and discussion
3.1. Overall structure of SeKatG-W78F
The structure of INH-bound SeKatG-W78F was reﬁned at 3.2 Å
resolution to R and Rfree values of 0.18 and 0.26, respectively. The
asymmetric unit contained one subunit of a SeKatG molecule
including a protoporphyrin IX hememoiety, and two cations (mod-
eled as sodium ions). The crystallographic equivalent subunit was
created by a 2-fold symmetry operation to form the functional
dimer (Fig. 2A). Although the electron density for SeKatG-W78F
was mostly continuous, the densities for the N-terminal segment
(residues 1–11) and C-terminal segment (719–720) were poorly
deﬁned; accordingly, these residues were not included in the
model. When the structure of INH-bound SeKatG-W78F was super-
posed on that of the INH-free SeKatG, no signiﬁcant structural
changes were observed in the enzyme; the root-mean-square
(rms) deviation for the Ca atoms was 0.37 Å.
3.2. Binding site of the INH molecule in SeKatG-W78F
The electron-density map of SeKatG-W78F was slightly
obscured due to the low-resolution data (3.2 Å), but comparison
of the electron-density maps unambiguously revealed the binding
position of the INH molecule. In the case of the INH-free wild-type
SeKatG (Fig. 2B) [17] and INH-bound wild-type SeKatG (Fig. 2C)
[14], the map around the heme propionate moiety clearly showed
that water molecules occupied in this space. By contrast, the Fo–Fc
map of the SeKatG-W78F crystal soaked with INH solution revealed
a positive density (>3r) at the corresponding position (Fig. 2E). In
the same manner, we conﬁrmed that the Fo–Fc maps of SeKatG-
W78F crystals soaked with or without the INH solution yielded
consistent results (Fig. 2D and E). Thus, we attributed the electron
density in the Fo–Fc map to the bound INH molecule. The bound
INH molecule was held in position in the space between the propi-
onate moiety of heme and Phe78 by a hydrogen bond: the distance
between the O atom of the Thr307 hydroxyl moiety and the N3
atom of the INH hydrazide moiety was 2.7 Å. Namely, the INHmol-
ecule was trapped inside the heme pocket in SeKatG-W78F.
In the structure of INH-bound wild-type SeKatG determined at
2.12 Å resolution [14], we could assign three INH molecules, but
all of the bound INH molecules were located on the protein surface
(Fig. 1). In addition, all interactions between KatG and the bound
INH molecules seemed to be weak, mediated only by van der
Waals contacts. Therefore, the one-residue substitution of W78F
in SeKatG dramatically changed the INH binding site.
3.3. Enzymatic and structural alterations of SeKatG by introducing the
W78F mutation
The steady-state kinetics of INH activation revealed that the kcat
values were almost unchanged by introducing the W78F mutation
(Table 2), though this mutation slightly increased the afﬁnity
(decrease in Km value) of KatG for INH by more than 4-fold relative
to the wild type. Thus, it is likely that the Trp78 residue is not
directly involved in the catalytic reaction of the INH activation,
S. Kamachi et al. / FEBS Letters 589 (2015) 131–137 135but instead hampers invasion of the heme pocket by the INH mol-
ecule. This result is probably consistent with the reported EPR
results that [Fe(IV)@O Trp106 (corresponding to the W78 in
SeKatG)] did not involved in the reaction with INH [13].
In the structure of INH-bound wild-type SeKatG, one INH mole-
cule was bound to the outside of the entrance of heme pocket and
interacted with W78 residue via a van der Waals contact (Fig. 3A)
[14]; apparently, this INH molecule was unable to enter the heme
pocket due to steric obstruction by the lid residue Trp78, which is
located at the entrance on the c-edge side of the heme. In the
W78F mutant, the bulky side-chain of the indole ring of Trp is
replaced by the slightly smaller benzyl ring of Phe. We assumed
that changing the lid residue in this manner would enlarge the
access channel. As expected, structural comparison between the
wild type and W78F demonstrated that in SeKatG-W78F the access
channel was slightly enlarged, and the heme could be seen appre-
ciably from the outside (Fig. 3B); by contrast, in the wild type, the
access channel was almost covered by the W78 residue. The
entrance size of the access channel in SeKatG-W78F was estimated
to about 4.7 Å (width)  1.2 Å (height), based on van der Waals
radii. Thus, the entrance may be too small for the INH molecule
to invade the heme pocket; based on the size of the INH molecule,
entry would require an entrance of at least 6 Å (width)  3.5 Å
(height).
A thermal-shift assay provided insight into how the INH mole-
cule could enter the heme pocket despite the restricted size of the
access channel (Fig. 3C). The denaturing temperature curve for
SeKatG dramatically changed upon introduction of the W78F
mutation; wild-type SeKatG exhibited a bi-modal curve, in which
the thermal denaturation temperatures (Tm) were around 54.5 C.Fig. 4. A structural comparison of the INH-binding sites of SeKatG-W78F, BpKatG-D14
(purple) and (A) INH-bound BpKatG-D141A (PDB ID: 4KA6 [10]) (green), (B) the INH-bou
bound form of the ascorbate peroxidase APX (PDB ID: 2VCF [28]) (light pink), (D) APX in
pink). The hemes are shown in pink. The bound INH molecule from SeKatG is shown in ye
molecule bound in APX is shown in orange.This bi-modal curve also revealed a local minimum of Tm at
49.5 C, indicating that the denaturation process (thermal stability
states) in wild-type SeKatG has two steps or that two different
states are present in solution. By contrast, the W78F mutation
changed the curve to a mono-modal pattern, with a Tm of
49.5 C. This change indicates that the W78F mutation affected
protein stability. One possible explanation is that the W78F muta-
tion increased the ﬂexibility of the SeKatG molecule, so that the
INH molecule could easily invade the heme pocket through the
access channel on the c-edge side of heme, even though the chan-
nel in the crystalline state was too small.
3.4. Structural comparisons among the INH-bound KatG and the
canonical peroxidases
To date, several groups have reported that INH molecule(s) can
bind in the heme pocket: one study examined the BpKatG-D141A
mutant [10], and the other two investigated the plant class I perox-
idases [27,28]. The recently reported structure of BpKatG contain-
ing the D141A mutation demonstrated that the INH molecule
could also enter/bind the heme cavity by removing the lid residue
(D141) at the d-edge entrance to the funnel-shaped heme cavity
(Fig. 4A) [10]. In this structure, the N3 nitrogen atom of the INH
molecule directly coordinates to the heme iron in the heme pocket.
The binding position of INH, as seen in BpKatG-D141A, may be
identical to that of hydrogen peroxide, an authentic substrate for
peroxidase/catalase reaction, or heme enzyme inhibitors such as
cyan or azide. In the cytochrome c peroxidase (CCP), a typical class
I peroxidase, INH molecule was also bound to the d-edge of the
heme (Fig. 4B), but the position and conﬁguration of the bound1A, CCP and APX. Superposition of the heme pocket in INH-bound SeKatG-W78F
nd form of the cytochrome c peroxidase CCP (PDB ID: 2V2E [28]) (gray), (C) the INH-
complex with ascorbate, a physiological electron donor (PDB ID: 1OAF [32]) (light
llow, and those from BpKatG, CCP and APX are shown in dark yellow. The ascorbate
Fig. 5. A structural comparison of the BHA/SHA-binding sites of ARP, HRP and APX. The heme cavity in (A) BHA-bound ARP (PDB ID: 1HSR [33]) (blue), (B) BHA-bound HRP
(PDB ID: 2ATJ [34]) (moss green), (C) SHA-bound ARP (PDB ID: 1CK6 [35]) (blue), (D) SHA-bound APX (PDB ID: 1V0H [36]) (light pink). The hemes are shown in pink. The
bound BHA molecule and SHA molecule are shown in light brown and brown. The ascorbate molecule bound in APX is shown in orange. Water molecules are shown as red
balls, and the red broken line indicates a hydrogen bond.
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bate peroxidase (APX), a structurally similar class I peroxidase, two
INH molecules can also bind in the heme pocket (Fig. 4C) [28].
Although one INH molecule in APX is located at the distal side of
the heme, its position/conﬁguration is slightly different from that
of the INH in BpKatG-D141A and CCP. The other INH in the APX
is near the propionate side chain of the heme. This binding position
is similar to that of INH-bound SeKatG-W78F.
The peroxidases have a rather low speciﬁcity for the electron
donor, since they could utilize not only the physiological com-
pound but also the various reagents including the artiﬁcial electron
donor. The extensive structural studies so far revealed that in the
heme pocket of the peroxidases the hydrophobic site(s) exists,
and this site functioned as the electron donor binding. For example,
the several peroxidases in complex with the benzhydroxamic acid
(BHA) or salicylhydroxamic acid (SHA), which is deemed as the
structural analogue of INH, have been reported. In most of the
peroxidases such as Arthromyces ramosus peroxidase (ARP), horse-
radish peroxidase (HRP) and APX, the aromatic reagents were
bound to the d-edge of the heme pocket [29] (Fig. 5); the conﬁgu-
rations of the bound aromatic reagents were similar to each other,
indicating the similar environment of the binding site. In the
above-mentioned CCP in complex with INH, the INH molecule
was also bound to the d-edge of the heme pocket (Fig. 4B). Notably,
in the APX one of the INH molecule as well as the ascorbate, a
physiological electron donor, was bound to the c-edge of the heme
pocket (Fig. 4D), as seen in the bound INH in the SeKatG W78F.
The access channel of the heme pocket is completely different
among the peroxidases and KatGs; the peroxidases have the wide
accessible channel to the d- and c-edge of the heme, in contrast the
wild-type KatG has a closed inaccessible channel even for the smallinorganic compound such as the INH. Thus the binding site in
SeKatG W78F is probably the ‘‘pseudo’’ binding site by introducing
the mutation, but this structural result implicates a similar nature
between the SeKatG and APX, that is, the INH potentially could
bind to the c-edge of the heme. Interestingly, similar to the SeKatG,
the reported radical intermediate in the APX is [Fe(IV@O) Porphy-
rin+] specie [30], not a proximal Trp specie, thus the electron
donor binding site may be potentially reﬂect the radical intermedi-
ate site. However, this idea is still highly controversial because sev-
eral electron-transfer pathways have been reported in KatGs
[13,20,31], implying the existence of an alternative INH binding/
activating site. In addition, the crystal structure of the INH-bound
wild-type SeKatG also demonstrated the three INH molecules
could bind on the molecular surface [14], all of which are com-
pletely different sites in MtKatG. These results strongly implicated
that SeKatG has the unique INH binding sites as compared to the
MtKatG and BpKatG. To reveal the exact reaction mechanism
underlying INH activation by each KatG, further spectroscopic, bio-
chemical, and structural studies are needed. The mutational stud-
ies will be especially important for the further understanding. Our
results here provided the one-residue substitution of W78F in
SeKatG dramatically changed the INH binding site. Such an unex-
pected result serves as a cautionary note for mutational experi-
ments in which functional changes of mutated proteins are
interpreted without knowledge of their exact structures.
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